ストックスクリーナーアプリを入手
764.37
2.04%
16.18
アフターアワーズ：
763.15
-1.22
-0.16%
Lilly Eli Co (LLY) 最新ニュース
Lilly weight-loss pill could be FDA-approved by year-end - Reuters
Eli Lilly and Company Announces Plans to Build $5 Billion Manufacturing Facility in Virginia - MarketScreener
U.S. FDA sends drug advertising warning letters to Lilly, Novo, Hims - Reuters
FDA Flags Eli Lilly's Weight-Loss Drug Video For Misleading Claims - Benzinga
Drugmaker Eli Lilly to build $5 billion facility in Goochland - Richmond Times-Dispatch
Eli Lilly to invest $5B on Virginia plant amid Trump's pharma tariff threats - Fox Business
Drug manufacturer Eli Lilly to build plant in Goochland, create 650 permanent jobs - yahoo.com
Eli Lilly's new $5B Virginia facility to target cancer, other drugs - upi.com
Eli Lilly and Company to invest in $5 billion facility in Goochland, Youngkin announces - WRIC ABC 8News
Eli Lilly (LLY) Faces Investor Concerns Over Recent Trial Data - GuruFocus
Eli Lilly To Invest $5 Billion In New Virginia Manufacturing Facility To Support Cancer Drugs Manufacturing - Benzinga
Eli Lilly (LLY) Commits $5B to New Manufacturing Facility in Vir - GuruFocus
Eli Lilly to invest $5 billion in new Virginia plant as pharma braces for tariffs - Reuters
Hershey, Eli Lilly, energy stocks - TradingView
Eli Lilly (LLY) Plans $5 Billion Manufacturing Facility in Virgi - GuruFocus
Eli Lilly Bets $5 Billion On New Virginia Plant - Finimize
Eli Lilly to invest $5 billion in new Virginia plant as pharma braces for tariffs By Reuters - Investing.com
Lilly announces plans to build $5 billion manufacturing facility in Virginia - Eli Lilly and Company
Eli Lilly to build $5B plant in Virginia—first of 4 U.S. sites to be named this year - Indianapolis Business Journal
UK has gone from a leader to a laggard in biopharma, Eli Lilly CEO says - CNBC
$5 Billion Manufacturing Plant: Lilly's Massive Virginia Investment Creates 2,450 Jobs, Leads U.S. Expansion - Stock Titan
Wegovy's Next Step: Novo Nordisk Eyes Approval for Higher-Dose Treatment - Benzinga
Eli Lilly (LLY) Faces Potential Competition from Novo's High-Dos - GuruFocus
Eli Lilly Issues Rare 40-Year Bond - Global Finance Magazine
JPMorgan Chase & Co. Issues Pessimistic Forecast for Eli Lilly and Company (NYSE:LLY) Stock Price - MarketBeat
JPMorgan Adjusts Price Target on Eli Lilly and Co. to $1,050 From $1,100, Maintains Overweight Rating - MarketScreener
Eli Lilly Fights $278M Drug Royalties Ruling At 9th Circ. - Law360
Rep. Julie Johnson Sells Eli Lilly and Company (NYSE:LLY) Stock - MarketBeat
Bearish Sentiment Surrounds Eli Lilly (LLY) as Stock Dips - GuruFocus
Lilly Moves Past 50-Day SMA: Should You Consider Buying the Stock Now? - Yahoo Finance
Eli Lilly Thinks Twice About Lab Investment, Adding To UK Gloom - insights.citeline.com
Eli Lilly and Company (LLY) Unveils AI Platform to Enhance Drug Discovery - MSN
Novo Nordisk Shares Rise as Obesity Trial Results Narrow Gap With Eli Lilly - uk.finance.yahoo.com
Jacobs & Co. CA Has $23.86 Million Stock Holdings in Eli Lilly and Company $LLY - MarketBeat
Eli Lilly joins big pharma fallout over drug prices - The Observer
Novo Nordisk’s ongoing challenges; Summit’s Western data disappoint; Eli Lilly offers free AI access to startups; and more - Endpoints News
Pharma's UK frustrations come to a head as Lilly, Sanofi, AZ pause investments - FirstWord Pharma
Astra, Lilly are latest to reevaluate U.K. investments after Merck’s pullback: reports - MSN
Eli Lilly Loses Appeal Over Medicaid Drug Pricing Fraud Case - Benzinga
Eli Lilly, Novo Nordisk prepare to face off in the next obesity drug battleground - CNBC
Eli Lilly (LLY) Gains Edge in Obesity Market - GuruFocus
Lilly Is Angling For Approval Of Its Obesity Pill. Is It Now A Buy? - Investor's Business Daily
Lilly launches AI-enabled drug discovery platform - Health Tech World
Takeda taps longtime Lilly exec as US head—Chutes & Ladders - Fierce Biotech
Ousted FDA official joins Lilly; Novo names global research head as layoffs come into focus - Endpoints News
1 Super Stock Down More Than 20% to Buy Hand Over Fist, According to Wall Street - AOL.com
Why Eli Lilly's Stock Could Be Gearing Up for a Big Rally - AOL.com
Medical company Eli Lilly plans to build $5.9 billion manufacturing campus in Houston - Click2Houston
7th Circ. Backs $183M FCA Award Over Eli Lilly Drug Rebates - Law360
Eli Lilly launches TuneLab to share AI drug discovery models with biotechs - drugdiscoverytrends.com
Takeda recruits Lilly executive to run US operations out of Cambridge - The Boston Globe
Eli Lilly loses appeal of $183.7 million Medicaid fraud award - MSN
Eli Lilly (LLY) Ordered to Pay $183.7M for Medicaid Fraud - GuruFocus
Eli Lilly (LLY) Taps Oscar-Winning Actress Julianne Moore for Brain Health Campaign - TipRanks
FILE PHOTO: Eli Lilly logo is shown on one of their offices in San Diego - Colorado Springs Gazette
Eli Lilly’s Phase 1 Study of LY3985297: Key Insights for Investors - TipRanks
Eli Lilly Loses Appeal of $193 Million Award in Fraud Suit (1) - Bloomberg Law News
Chelsea Counsel Co. Sells 925 Shares of Eli Lilly and Company $LLY - MarketBeat
Lilly to participate in Bernstein's 2nd Annual Healthcare Forum - Eli Lilly and Company
0.53%
0.12%
大文字化:
|
ボリューム (24 時間):